AmpliPhi Biosciences (TGEN) Announces First Closing of $2.7 Million
11/17/2011 7:02:19 AM
RICHMOND, Va. & SEATTLE, Wa. & COLWORTH, UK--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (APHB.PK), the leader in the development of bacteriophage-based anti-bacterial therapies to treat drug resistant infections, has announced that is has closed on an initial amount of $2.7M in equity investment and convertible loan notes to support the further progress of the Company. In total, the Company is seeking up to $5m in this round.